Cisapride
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171905This classification denotes an antiemetic agent with the molecular formula C23H29ClFN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UVL329170W, chemically known as benzamide, 4-amino-5-chloro-n-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, cis- but generally known as cisapride, which bears US NIH Compound Identifier 2769. European Medicines Agency schedules Cisapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07479MIG. The term CISAPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules cisapride in its Anatomical Therapeutic Chemical (ATC) Classification. CISAPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cisapride under HS 29333999 and SITC 51574. As of Q4 2014, CISAPRIDE remains the US FDA Preferred Term for this commodity. Cisapride bears US NLM identifiers UMLS ID C0072916 and NCI Concept Code C1210. SMILES: CLC1CC(C(=O)NC2C(OC)CN(CC2)CCCOC2CCC(F)CC2)C(OC)CC1N.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.